120 Participants Needed

Transcranial Stimulation for Memory Loss

(GWI HDtDCS Trial)

SS
KY
EM
JR
MM
Overseen ByMichael Motes, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas at Dallas
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment called High Definition transcranial Direct Current Stimulation (HD tDCS) to help Gulf War veterans improve word retrieval. Veterans with Gulf War Illness often struggle with this, making conversations and memory recall difficult. The trial uses gentle electrical stimulation on specific brain areas to determine if it can enhance verbal skills. Ideal participants are veterans who served in the Gulf War, speak English, and experience word retrieval issues. The goal is to enhance daily communication abilities with minimal side effects. As an unphased trial, this study offers veterans the chance to contribute to innovative research that could improve communication skills.

Will I have to stop taking my current medications?

You may need to stop taking certain medications that interact with the treatment, such as amphetamines, L-dopa, and citalopram, among others. It's important to discuss your current medications with the study team to determine if any changes are necessary.

What prior data suggests that this treatment is safe?

Research has shown that High Definition transcranial Direct Current Stimulation (HD tDCS) is generally safe for people. Studies have found that a similar treatment, tDCS, can be safely used for up to 20 days. This treatment applies a weak electrical current to the head to influence brain activity.

Past studies revealed no major differences in thinking skills between those who received HD tDCS and those who received a fake (inactive) treatment. This suggests that the treatment is well-tolerated, with few side effects reported.

Overall, HD tDCS appears to be a safe choice for those considering participation in clinical trials. However, discussing any concerns with the study team is important.12345

Why are researchers excited about this trial?

Unlike traditional treatments for memory loss, which often rely on medications or cognitive therapies, High Definition Transcranial Direct Current Stimulation (HD tDCS) offers a non-invasive and targeted approach. Researchers are excited about HD tDCS because it uses low electrical currents to stimulate specific brain regions, potentially enhancing neural activity and improving memory function. This technique could provide a more direct and immediate effect on brain function compared to the gradual changes seen with medication or therapy, making it a promising option for quicker, more precise interventions.

What evidence suggests that High Definition Transcranial Direct Current Stimulation is effective for improving verbal retrieval in Gulf War Illness?

Research has shown that High Definition transcranial Direct Current Stimulation (HD tDCS), which participants in this trial may receive, might improve thinking skills. It has potential benefits for people with vascular cognitive impairment, possibly aiding memory tasks. However, one small study found that improvements in thinking skills were not significantly different from a fake treatment immediately after therapy. In this trial, some participants will receive Sham HD tDCS as a control. Other studies suggest HD tDCS can help with memory in some groups, such as those with Alzheimer's disease. This treatment uses small electric currents to stimulate specific brain areas, potentially enhancing memory and speaking skills. Although results vary, there is hope it can assist people with Gulf War Illness in finding words and improving conversation skills.13567

Who Is on the Research Team?

JH

John Hart, Jr, MD

Principal Investigator

The University of Texas at Dallas

Are You a Good Fit for This Trial?

This trial is for US Gulf War veterans who served between 1990-1991, are right-handed, and were aged 18-50 during service. Participants must understand English and be able to consent. Excluded are those with neurological disorders, severe TBI, drug abuse history, certain medication use, pacemakers or metal in the head.

Inclusion Criteria

I am fluent in English.
My gender, race, or military rank does not exclude me from this trial.
US military veterans serving during the 1990-1991 GW and were deployed to the theater of operations in Southwest Asia (i.e., Iraq, Kuwait, and Saudi Arabia) who are capable of understanding and signing an informed consent document
See 1 more

Exclusion Criteria

I am not fluent in English.
I have a history of serious brain conditions or injuries.
I don't have a pacemaker, medication pumps, severe heart disease, or non-removable metal near my head.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 10 sessions of HD tDCS or sham over the preSMA region, 20 minutes per session, over a two-week period

2 weeks
10 visits (in-person)

Follow-up

Participants are monitored for changes in verbal retrieval performance and ERP markers at 3 and 6 months post-treatment

6 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • High Definition Transcranial Direct Current Stimulation
  • Sham High Definition Transcranial Direct Current Stimulation
Trial Overview The study tests High Definition transcranial Direct Current Stimulation (HD tDCS) on brain regions linked to word retrieval in Gulf War Illness patients. It compares active HD tDCS against a sham (inactive) treatment over ten sessions to see if it improves verbal abilities.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Active HD tDCSActive Control1 Intervention
Group II: Sham HD tDCSPlacebo Group1 Intervention

High Definition Transcranial Direct Current Stimulation is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as HD-tDCS for:
🇪🇺
Approved in European Union as HD-tDCS for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas at Dallas

Lead Sponsor

Trials
71
Recruited
108,000+

University of Texas Southwestern Medical Center

Collaborator

Trials
1,102
Recruited
1,077,000+

Published Research Related to This Trial

Transcranial direct current stimulation (tDCS) significantly improved face-name associative memory in younger adults, with benefits lasting for 24 hours after stimulation, indicating its potential efficacy for enhancing memory in this age group.
In contrast, older adults did not show any improvement in memory performance with tDCS, suggesting that they may be less responsive to this type of cognitive intervention under the conditions tested.
Differential Age Effects of Transcranial Direct Current Stimulation on Associative Memory.Leach, RC., McCurdy, MP., Trumbo, MC., et al.[2020]
In a study involving 101 healthy young and older adults, multisession transcranial direct-current stimulation (tDCS) significantly improved memory recall, especially in older adults, with effects lasting up to three months after training.
The benefits of tDCS were most pronounced in individuals with lower baseline learning abilities, indicating its potential to help counteract memory impairments in both healthy individuals and those with cognitive challenges.
Multisession transcranial direct current stimulation facilitates verbal learning and memory consolidation in young and older adults.Perceval, G., Martin, AK., Copland, DA., et al.[2021]
Transcranial direct current stimulation (tDCS) was found to enhance working memory and learning potential in a study of 31 healthy older adults, with 16 receiving actual stimulation and 15 receiving a sham treatment.
The study demonstrated that tDCS is a safe and non-invasive method for improving cognitive functions in older adults, although it did not show significant effects on immediate memory.
Enhancing Immediate Memory, Potential Learning, and Working Memory with Transcranial Direct Current Stimulation in Healthy Older Adults.Satorres, E., Meléndez, JC., Pitarque, A., et al.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39863318/
High definition transcranial direct current stimulation as an ...The primary outcome was change in total learning and delayed recall on the Rey Auditory Verbal Learning Test (RAVLT) immediately post-treatment and at 8-weeks.
High definition transcranial direct current stimulation as an ...In this pilot trial, no statistically significant differences on cognitive outcomes were found between sham and active HD-tDCS immediately post-treatment (p's > ...
A systematic review and meta-analysis of the impact of ...People with AD showed greater improvements compared to those with MCI or dementia (SMD = 0.91, p = 0.02). However, tDCS did not significantly ...
High Definition Transcranial Direct Current Stimulation (HD ...This program and training model have been demonstrated to be effective and beneficial in patients with vascular cognitive impairment. In the CCT ...
A systematic review and meta-analysis of healthy adultsThis systematic review analyzed the current literature on anodal HD-tDCS for WM enhancement, investigating its effectiveness and the influence of different ...
Safety and feasibility of optimized transcranial direct current ...Previous research has shown that tDCS can be safely used for 20 days and has significant effects on cognitive function (11, 12). Although there ...
Systematic review and meta-analysis of transcranial ...We conducted a meta-analysis of twenty-two trials involving 1074 adults with mild cognitive impairment and Alzheimer's disease.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security